
PLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS, INC. (PLRX)
WebsitePrice
Market cap
Next catalystExpected 2027PLN-101095 — FORTIFY; dose escalation and indication expansion with pembrolizumab · Phase 1 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved